Home Featured Page 65

Featured

Latest

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

Senator Kirk Cullimore on Utah’s MDMA and Psilocybin Pilot Program

The Alexander Shulgin Research Institute and the Future of Psychedelic Drug...

The Psychedelic News Feed: April 1, 2024

Pα+ Psychedelic Patent Analysis: February 2024

PT499 – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological...

Pα+ Psychedelic Bulletin #160: Mutual Recognition for MDMA-AT in the UK?...

The Practitioner’s Guide to Psychedelic Integration Therapy

ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence...

PT498 – Traversing the Psychedelic Landscape: From Esalen and Millbrook to...

PT497 – Reflections from Shulgin Farm: Psychedelics, Legacy, and the Spirit...

EDITOR PICKS

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

Why Ketamine Is Changing Psychiatry

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits of Psychedelic Therapy

Why Ketamine Is Changing Psychiatry

Trump’s Psychedelics Executive Order: Reactions From Across the Field and Beyond

Pinco Güncel Giriş Şifrənizi Yeniləmənin Əhəmiyyəti

Senator Kirk Cullimore on Utah’s MDMA and Psilocybin Pilot Program

The Alexander Shulgin Research Institute and the Future of Psychedelic Drug...

The Psychedelic News Feed: April 1, 2024

Pα+ Psychedelic Patent Analysis: February 2024

PT499 – Mesoamerican Psychedelics, Decolonization, and the Concept of an Ontological...

Pα+ Psychedelic Bulletin #160: Mutual Recognition for MDMA-AT in the UK?...

The Practitioner’s Guide to Psychedelic Integration Therapy

ICER Draft Evidence Report on Lykos’ MDMA-Assisted Psychotherapy Deems Clinical Evidence...

PT498 – Traversing the Psychedelic Landscape: From Esalen and Millbrook to...

PT497 – Reflections from Shulgin Farm: Psychedelics, Legacy, and the Spirit...

EDITOR PICKS

Breaking: FDA Awards Priority Review Vouchers to Otsuka, Compass, and Usona

Erica Rex: Seeing What Is There, Trauma, Integration, and the Limits...

Why Ketamine Is Changing Psychiatry

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY